Effectiveness of Adjuvanted Recombinant Zoster Vaccine (RZV) Against Postherpetic Neuralgia (PHN) and Against Cardiovascular Disease (CVD) Events After Herpes Zoster (HZ) in United States Adults in Medicare Fee-for-Service (FFS) + Inovalon’s MORE2 Registry (307298 - EPI-ZOSTER-116 VE DB US)

01/10/2026
01/10/2026
EU PAS number:
EUPAS1000001125
Study
Planned
Documents
Study protocol
Initial protocol
English (1.89 MB - PDF) View document
Study results
Study report
Other information